Employment Agreements in the Pharmaceuticals Industry

2,868 Contracts & Agreements

Browse by Company

60 DEGREES PHARMACEUTICALS, INC. (6 contracts)
Acacia Diversified Holdings, Inc. (4)
Acasti Pharma Inc. (1)
Accelerated Pharma, Inc. (7)
ACELRX PHARMACEUTICALS INC (1)
Acer Therapeutics Inc. (15)
ACHILLION PHARMACEUTICALS INC (27)
Aclaris Therapeutics, Inc. (17)
Acreage Holdings, Inc. (3)
ACURA PHARMACEUTICALS, INC (15)
Adamis Pharmaceuticals Corp (19)
ADIAL PHARMACEUTICALS, INC. (14)
Aegerion Pharmaceuticals, Inc. (28)
AEOLUS PHARMACEUTICALS, INC. (6)
AEON Biopharma, Inc. (2)
AERIE PHARMACEUTICALS INC (15)
Aerpio Pharmaceuticals, Inc. (14)
AGILE THERAPEUTICS INC (14)
Akers Biosciences, Inc. (21)
Akorn (7)
ALGORX PHARMACEUTICALS INC (1)
ALIMERA SCIENCES INC (24)
ALSERES PHARMACEUTICALS INC (7)
Altus Pharmaceuticals Inc. (1)
Amag Pharmaceuticals (26)
AmeriCann, Inc. (1)
Amneal Pharmaceuticals, Inc. (15)
Amphastar Pharma (5)
Ampio Pharmaceuticals, Inc. (33)
AMYLIN PHARMACEUTICALS INC (7)
Amylyx Pharmaceuticals, Inc. (13)
Anebulo Pharmaceuticals, Inc. (6)
Angion Biomedica Corp. (4)
ANGIOTECH PHARMACEUTICALS INC (11)
ANI Pharma Inc (12)
Anthera Pharmaceuticals Inc (12)
APP Pharmaceuticals, Inc. (3)
Applied BioSciences Corp. (1)
APRICUS BIOSCIENCES, INC. (22)
Aquestive Therapeutics, Inc. (15)
ARADIGM CORP (2)
Aralez Pharmaceuticals Inc. (12)
ARIAD PHARMACEUTICALS INC (37)
ARTELO BIOSCIENCES, INC. (3)
Artemis Therapeutics, Inc. (4)
ARVINAS, INC. (5)
Aspreva Pharmaceuticals CORP (4)
Assertio Holdings, Inc. (1)
Astex Pharmaceuticals, Inc (3)
ATAI Life Sciences B.V. (6)
Atea Pharmaceuticals, Inc. (6)
Athira Pharma, Inc. (7)
AUXILIUM PHARMACEUTICALS INC (44)
AVADEL PHARMACEUTICALS PLC (18)
AVANIR PHARMACEUTICALS, INC. (3)
AVENUE THERAPEUTICS, INC. (1)
AYTU BIOSCIENCE, INC (20)
Bakhu Holdings, Corp. (3)
BARR PHARMACEUTICALS INC (24)
Baudax Bio, Inc. (4)
Bausch Health Companies Inc. (13)
BENTLEY PHARMACEUTICALS INC (2)
Bespoke Extracts, Inc. (7)
Big Rock Partners Acquisition Corp. (3)
BIODELIVERY SCIENCES INTERNATIONAL INC (17)
Biofrontera Inc. (8)
Biohaven Ltd. (2)
BiondVax Pharmaceuticals Ltd. (3)
BioPharmX Corp (5)
Biostar Pharmaceuticals, Inc. (3)
Blue Water Acquisition Corp. (4)
BODY & MIND INC. (2)
Boston Therapeutics, Inc. (4)
Braeburn Pharmaceuticals, Inc. (5)
Bright Green Corp (6)
CADENCE PHARMACEUTICALS INC (2)
CALLISTO PHARMACEUTICALS INC (5)
Canbiola, Inc. (15)
Cancer Prevention Pharmaceuticals, Inc. (3)
Cannabics Pharmaceuticals Inc. (4)
CANNAPHARMARX, INC. (1)
Canopy Growth Corp (8)
Cara Therapeutics, Inc. (11)
CARDAX, INC. (5)
CASSAVA SCIENCES INC (5)
Catalent Inc (8)
Celator Pharmaceuticals Inc (2)
CELGENE CORP (4)
Cerecor Inc. (14)
Charlotte's Web Holdings, Inc. (3)
CHIASMA, INC (15)
CHINA PEDIATRIC PHARMACEUTICALS, INC. (3)
CHINA PHARMA HOLDINGS, INC. (2)
China Pharmaceuticals Inc (3)
CinCor Pharma, Inc. (4)
Cingulate Inc. (17)
Citius Pharmaceuticals, Inc. (5)
Clearside Biomedical, Inc. (9)
Clever Leaves Holdings Inc. (5)
CLS Holdings USA, Inc. (26)
CNS Pharmaceuticals, Inc. (3)
Cocrystal Pharma, Inc. (8)
COGNITION THERAPEUTICS INC (4)
COLLEGIUM PHARMACEUTICAL, INC (23)
CoLucid Pharmaceuticals, Inc. (2)
Columbia Care Inc. (7)
Context Therapeutics Inc. (2)
Corcept Therapeutics Incorporated (4)
CorMedix Inc. (22)
CPEX Pharmaceuticals, Inc. (2)
Cronos Group Inc. (18)
CUMBERLAND PHARMACEUTICALS INC (51)
Cure Pharmaceutical Holding Corp. (6)
Cyteir Therapeutics, Inc. (3)
Dermata Therapeutics, Inc. (12)
Dova Pharmaceuticals Inc. (7)
DUSA PHARMACEUTICALS INC (23)
Egalet Corp (15)
Elanco Animal Health Inc (1)
Eleison Pharmaceuticals Inc (1)
ELITE PHARMACEUTICALS INC (10)
Eloxx Pharmaceuticals, Inc. (12)
Endexx Corp (1)
Endo International plc (24)
Endo Pharmaceuticals Solutions Inc. (7)
EPHS HOLDINGS, INC. (1)
EPIX Pharmaceuticals, Inc. (13)
Evofem Biosciences, Inc. (10)
Evoke Pharma Inc (5)
Evolus, Inc. (11)
Exactus, Inc. (10)
EYEGATE PHARMACEUTICALS INC (6)
EYENOVIA, INC. (14)
EyePoint Pharmaceuticals, Inc. (13)
EYETECH PHARMACEUTICALS INC (12)
FERMAVIR PHARMACEUTICALS, INC. (1)
Foamix Pharmaceuticals Ltd. (3)
Fresenius Kabi Pharmaceuticals Holding, Inc. (2)
FRONTIER OILFIELD SERVICES INC (9)
Fulcrum Therapeutics, Inc. (17)
GB SCIENCES INC (12)
GRAYBUG VISION, INC. (1)
GridIron BioNutrients, Inc. (2)
GUILFORD PHARMACEUTICALS INC (2)
Harmony Biosciences Holdings, Inc. (2)
HARROW HEALTH, INC. (9)
Haymaker Acquisition Corp. III (7)
Horizon Pharma plc (36)
Hoth Therapeutics, Inc. (14)
iANTHUS CAPITAL HOLDINGS, INC. (2)
IDENIX PHARMACEUTICALS INC (9)
Ikena Oncology, Inc. (1)
IMAGING3 INC (1)
IMARA Inc. (8)
IMMTECH PHARMACEUTICALS, INC. (1)
INNOVATE BIOPHARMACEUTICALS, INC. (18)
Innovive Pharmaceuticals, Inc. (1)
INSPIRE PHARMACEUTICALS INC (5)
IntelGenx Technologies Corp. (11)
Intra-Cellular Therapies, Inc. (14)
ISTA PHARMACEUTICALS INC (1)
Iterum Therapeutics plc (7)
Jaguar Health, Inc. (3)
JAVELIN PHARMACEUTICALS, INC (5)
Jazz Pharmaceuticals plc (17)
Jiangbo Pharmaceuticals, Inc. (1)
Johnson & Johnson (1)
Journey Medical Corp (2)
JUNIPER PHARMACEUTICALS INC (18)
Jushi Holdings Inc. (12)
Kaleido Biosciences, Inc. (7)
Kannalife Inc (4)
KEMPHARM, INC (17)
KING PHARMACEUTICALS INC (1)
KOS PHARMACEUTICALS INC (2)
Landos Biopharma, Inc. (4)
Lannett Company, Inc. (30)
Lev Pharmaceuticals Inc (4)
Level Brands, Inc. (13)
Lexaria Bioscience Corp. (3)
LIPELLA PHARMACEUTICALS INC (5)
Lipocine Inc. (7)
Liquidia Corp (5)
Liquidia Technologies Inc (4)
Longboard Pharmaceuticals, Inc. (1)
Lowell Farms Inc. (1)
Luckwel Pharmaceuticals Inc. (6)
Lyra Therapeutics, Inc. (8)
Mallinckrodt (18)
MAP Pharmaceuticals, Inc. (4)
Marijuana Co of America, Inc. (3)
MARINUS PHARMACEUTICALS INC (17)
MAXIM PHARMACEUTICALS INC (9)
Medicine Man Technologies, Inc. (16)
MedMen Enterprises, Inc. (2)
MEMORY PHARMACEUTICALS CORP (6)
Merck (10)
MICROCHANNEL TECHNOLOGIES CORP (4)
MiddleBrook Pharmaceuticals, Inc. (6)
Milestone Pharmaceuticals Inc. (9)
Mind Medicine (MindMed) Inc. (5)
MIRA PHARMACEUTICALS, INC. (7)
MJ Holdings, Inc. (10)
Molecular Insight Pharmaceuticals, Inc. (8)
Mylan N.V. (11)
MYnd Analytics, Inc. (4)
MyoKardia Inc (3)
Nabriva Therapeutics plc (11)
NEKTAR THERAPEUTICS (3)
Neos Therapeutics, Inc. (16)
Neuralstem, Inc. (12)
NewBridge Global Ventures, Inc. (14)
NGM BIOPHARMACEUTICALS INC (7)
Notis Global, Inc. (4)
NovaBay Pharmaceuticals, Inc. (25)
Novan, Inc. (15)
NOVEN PHARMACEUTICALS INC (2)
NPS PHARMACEUTICALS INC (11)
NUCRYST Pharmaceuticals Corp. (4)
NURX PHARMACEUTICALS, INC. (1)
OCULAR THERAPEUTIX, INC (20)
Omthera Pharmaceuticals, Inc. (4)
OncoMed Pharmaceuticals Inc (2)
Onconova Therapeutics, Inc. (14)
OPIANT PHARMACEUTICALS, INC. (9)
OptiNose, Inc. (22)
ORAMED PHARMACEUTICALS INC. (25)
OSCIENT PHARMACEUTICALS CORP (2)
OSI PHARMACEUTICALS INC (7)
Osmotica Pharmaceuticals plc (5)
OTONOMY, INC. (11)
Pacira Pharmaceuticals, Inc. (27)
Paratek Pharmaceuticals, Inc. (10)
PaxMedica, Inc. (3)
PEAK PHARMACEUTICALS, INC. (1)
Perrigo (15)
PetLife Pharmaceuticals, Inc. (1)
Petros Pharmaceuticals, Inc. (1)
PHARMOS CORP (4)
Phathom Pharmaceuticals, Inc. (6)
Phibro Animal Health Corporation (8)
Phoenix Life Sciences International Limited. (1)
Pivot Pharmaceuticals Inc. (3)
Planet 13 Holdings Inc. (1)
PLAYERS NETWORK (2)
PLx Pharma Inc. (23)
Prestige Brands Holdings Inc (7)
PRESTWICK PHARMACEUTICALS INC (1)
Processa Pharmaceuticals, Inc. (4)
Profile Solutions, Inc. (2)
ProPhase Labs, Inc. (4)
PROTEO INC (2)
PROVECTUS BIOPHARMACEUTICALS, INC. (24)
Provention Bio, Inc. (18)
Pulmatrix, Inc. (11)
QUANTA INC (4)
QUARK PHARMACEUTICALS INC (9)
QUESTCOR PHARMACEUTICALS INC (1)
RADIENT PHARMACEUTICALS Corp (1)
Rain Therapeutics Inc. (2)
Rani Therapeutics Holdings, Inc. (6)
REATA PHARMACEUTICALS INC (10)
Recro Pharma, Inc. (11)
Reliant Pharmaceuticals, Inc. (1)
RELMADA THERAPEUTICS, INC. (5)
RespireRx Pharmaceuticals Inc. (22)
resTORbio, Inc. (14)
Revance Therapeutics, Inc. (14)
Rib-X Pharmaceuticals, Inc. (1)
ROCK CREEK PHARMACEUTICALS, INC. (10)
Roivant Sciences Ltd. (4)
Sagent Pharmaceuticals, Inc. (11)
SALIX PHARMACEUTICALS LTD (5)
SAVIENT PHARMACEUTICALS INC (27)
SCICLONE PHARMACEUTICALS INC (2)
Scopus BioPharma Inc. (1)
scPharmaceuticals Inc. (4)
SCYNEXIS INC (6)
SenesTech, Inc. (5)
Sienna Biopharmaceuticals, Inc. (8)
SIGA TECHNOLOGIES INC (15)
Sirtris Pharmaceuticals, Inc. (4)
Sonoma Pharmaceuticals, Inc. (21)
Strongbridge Biopharma plc (1)
Sucampo Pharmaceuticals, Inc. (12)
Supernus Pharmaceuticals, Inc. (5)
SYNERGY PHARMACEUTICALS, INC. (19)
TAPESTRY PHARMACEUTICALS, INC (2)
Target Group Inc. (1)
Targeted Medical Pharma, Inc. (11)
TAURIGA SCIENCES, INC. (3)
Telomir Pharmaceuticals, Inc. (3)
Tenzing Acquisition Corp. (4)
Terns Pharmaceuticals, Inc. (11)
Terra Tech Corp. (13)
TerrAscend Corp. (3)
TETRALOGIC PHARMACEUTICALS CORP (8)
TEVA PHARMACEUTICAL INDUSTRIES LTD (28)
Textmunication Holdings, Inc. (3)
TFF Pharmaceuticals, Inc. (6)
The Medicines Company (4)
TherapeuticsMD, Inc. (12)
Theravance Biopharma, Inc. (1)
TIBET PHARMACEUTICALS, INC. (1)
Tilray, Inc. (12)
TILT Holdings Inc. (6)
TITAN PHARMACEUTICALS INC (21)
Trevi Therapeutics, Inc. (2)
Tribute Pharmaceuticals Canada Inc. (8)
Trubion Pharmaceuticals, Inc (6)
Trulieve Cannabis Corp. (11)
Upjohn Inc (1)
Urigen Pharmaceuticals, Inc. (4)
Urovant Sciences Ltd. (9)
VALEANT PHARMACEUTICALS INTERNATIONAL (5)
Valera Pharmaceuticals Inc (2)
Vallon Pharmaceuticals, Inc. (5)
Ventyx Biosciences, Inc. (1)
Verano Holdings Corp. (1)
Verrica Pharmaceuticals Inc. (12)
VIA Pharmaceuticals, Inc. (12)
VICURON PHARMACEUTICALS INC (2)
VION PHARMACEUTICALS INC (4)
VioQuest Pharmaceuticals, Inc. (1)
Vireo Health International, Inc. (17)
Virpax Pharmaceuticals, Inc. (10)
Vitae Pharmaceuticals, Inc (5)
Vitality Biopharma, Inc. (6)
VIVUS INC (5)
Vyrix Pharmaceuticals, Inc. (1)
Wave Life Sciences Ltd. (7)
WEED, INC. (6)
XANODYNE PHARMACEUTICALS INC (7)
Xeris Biopharma Holdings, Inc. (4)
XERIS PHARMACEUTICALS INC (9)
ZOGENIX, INC. (13)
Zomedica Pharmaceuticals Corp. (19)
Zynerba Pharmaceuticals, Inc. (17)

Recent Contracts

Rodrigues Employment Agreement, dated April 16, 2024, between the Company and Dominic Rodrigues (PROVECTUS BIOPHARMACEUTICALS, INC., Filed With SEC on April 16, 2024)
Pershing Employment Agreement, dated April 16, 2024, between the Company and Ed Pershing (PROVECTUS BIOPHARMACEUTICALS, INC., Filed With SEC on April 16, 2024)
Employment Agreement, dated as of April 12, 2024, by and between the Company and Mr. West (Jushi Holdings Inc., Filed With SEC on April 15, 2024)
Employment Agreement with Stanley Teeple dated February 8, 2024 (Canbiola, Inc., Filed With SEC on April 15, 2024)
Employment Agreement with Marco Alfonsi dated February 8, 2024 (Canbiola, Inc., Filed With SEC on April 15, 2024)
Executive Employment Agreement with Nelson Cabatuan dated March 14, 2024 (Lexaria Bioscience Corp., Filed With SEC on April 9, 2024)
Executive Employment Agreement, dated as of March 29, 2024 and Effective March 31, 2024, by and between Bright Green Corporation and Gurvinder Singh (Bright Green Corp, Filed With SEC on April 3, 2024)
Amendment to Employment Agreement, dated October 13, 2023, between MIRA Pharmaceuticals and Dr. Chris Chapman (MIRA PHARMACEUTICALS, INC., Filed With SEC on April 1, 2024)
Amendment to Executive Employment Agreement of Larry C. Heaton dated April 1, 2024 (Zomedica Pharmaceuticals Corp., Filed With SEC on April 1, 2024)
2023 Employment Inducement Award Plan and forms of award agreements thereunder (KEMPHARM, INC, Filed With SEC on April 1, 2024)
Seventh Amendment to Employment Agreement, dated September 6, 2023, by and between MyMD Pharmaceuticals, Inc. and Dr. Chris Chapman (Akers Biosciences, Inc., Filed With SEC on April 1, 2024)
Employment Agreement, dated April 7, 2021, by and between Virpax Pharmaceuticals, Inc. and Sheila Mathias (Virpax Pharmaceuticals, Inc., Filed With SEC on March 26, 2024)
Amended and Restated Employment Agreem (Mallinckrodt, Filed With SEC on March 26, 2024)
Form of Second Amended and Restated Employment Agreement for Executive Officers (Mallinckrodt, Filed With SEC on March 26, 2024)
Amendment to Executive Employment Agreement, dated December 1, 2022, by and between TILT Holdings Inc. and Mark Higgins (TILT Holdings Inc., Filed With SEC on March 22, 2024)
Executive Employment Agreement, dated September 24, 2021, by and between TILT Holdings Inc. and Mark Higgins (TILT Holdings Inc., Filed With SEC on March 22, 2024)
Executive Employment Agreement between Verano Holdings Corp. and Laura Kalesnik, dated March 1, 2021 (Verano Holdings Corp., Filed With SEC on March 15, 2024)
Employment Agreement, effective January 8, 2024, by and between BioTE Medical, LLC and Robert C. Peterson (Haymaker Acquisition Corp. III, Filed With SEC on March 15, 2024)
Amended and Restated Employment Agreement by and between the Registrant and Mark Vignola (Terns Pharmaceuticals, Inc., Filed With SEC on March 14, 2024)
Employment Agreement by and between the Registrant and Jill M. Quigley (Terns Pharmaceuticals, Inc., Filed With SEC on March 14, 2024)
Amended and Restated Employment Agreement by and between the Registrant and Bryan Yoon, Esq (Terns Pharmaceuticals, Inc., Filed With SEC on March 14, 2024)
Amended and Restated Employment Agreement by and between the Registrant and Erin Quirk, M.D (Terns Pharmaceuticals, Inc., Filed With SEC on March 14, 2024)
Anish Patel Confirmatory Employment Letter (IMARA Inc., Filed With SEC on March 14, 2024)
Joseph Lyssikatos Confirmatory Employment Letter (IMARA Inc., Filed With SEC on March 14, 2024)
Benjamin Hohl Confirmatory Employment Letter (IMARA Inc., Filed With SEC on March 14, 2024)
Helen Collins Confirmatory Employment Letter (IMARA Inc., Filed With SEC on March 14, 2024)
Sam Kintz Confirmatory Employment Letter, as amended and restated February 29, 2024 (IMARA Inc., Filed With SEC on March 14, 2024)
Employment Agreement, dated February 7, 2024, between Lee Fraser and BLC Management Company LLC (Planet 13 Holdings Inc., Filed With SEC on March 13, 2024)
Amended and Restated At-Will Employment Agreement dated March 11, 2024 between The Cannabist Company Holdings Inc. and Jesse Channon (attached herein as Exhibit 10.22 of the... (Columbia Care Inc., Filed With SEC on March 13, 2024)
Amended and Restated At-Will Employment Agreement dated March 11, 2024 between The Cannabist Company Holdings Inc. and David J. Hart (attached herein as Exhibit 10.21 of the... (Columbia Care Inc., Filed With SEC on March 13, 2024)
Employment Agreement dated March 7, 2024, effective as of January 1, 2024, by and between John M. Hamm and Cumberland Pharmaceuticals Inc (CUMBERLAND PHARMACEUTICALS INC, Filed With SEC on March 13, 2024)
Employment Agreement dated March 7, 2024, effective as of January 1, 2024, by and between Chris Bitterman and Cumberland Pharmaceuticals Inc (CUMBERLAND PHARMACEUTICALS INC, Filed With SEC on March 13, 2024)
Employment Agreement dated March 8, 2024, effective as of January 1, 2024, by and between Todd Anthony and Cumberland Pharmaceuticals Inc (CUMBERLAND PHARMACEUTICALS INC, Filed With SEC on March 13, 2024)
Employment Agreement dated March 8, 2024, effective as of January 1, 2024, by and between Jim Herman and Cumberland Pharmaceuticals Inc (CUMBERLAND PHARMACEUTICALS INC, Filed With SEC on March 13, 2024)
Employment Agreement dated March 8, 2024, effective as of January 1, 2024, by and between A.J. Kazimi and Cumberland Pharmaceuticals Inc (CUMBERLAND PHARMACEUTICALS INC, Filed With SEC on March 13, 2024)
Employment Agreement, by and between the Registrant and Dr. Sanjay Nayak, dated as of February 21, 2024 (OCULAR THERAPEUTIX, INC, Filed With SEC on March 11, 2024)
Fourth Amendment, dated January 8, 2024, to Employment Agreement, by and between Oramed Ltd. and David Silberman (ORAMED PHARMACEUTICALS INC., Filed With SEC on March 6, 2024)
Third Amendment, dated April 27, 2023, to Employment Agreement, by and between Oramed Ltd. and David Silberman (ORAMED PHARMACEUTICALS INC., Filed With SEC on March 6, 2024)
Amendment, dated January 8, 2024, to Employment Agreement by and between Oramed Ltd. and Nadav Kidron, entered into as of November 1, 2022 (ORAMED PHARMACEUTICALS INC., Filed With SEC on March 6, 2024)
Amendment, dated April 27, 2023, to Employment Agreement by and between Oramed Ltd. and Nadav Kidron, entered into as of November 1, 2022 (ORAMED PHARMACEUTICALS INC., Filed With SEC on March 6, 2024)